For: | Villarroel-Espindola F, Ejsmentewicz T, Gonzalez-Stegmaier R, Jorquera RA, Salinas E. Intersections between innate immune response and gastric cancer development. World J Gastroenterol 2023; 29(15): 2222-2240 [PMID: 37124883 DOI: 10.3748/wjg.v29.i15.2222] |
---|---|
URL: | https://www.wjgnet.com/2150-5330/full/v29/i15/2222.htm |
Number | Citing Articles |
1 |
Marek Kos, Krzysztof Bojarski, Paulina Mertowska, Sebastian Mertowski, Piotr Tomaka, Łukasz Dziki, Ewelina Grywalska. Immunological Strategies in Gastric Cancer: How Toll-like Receptors 2, -3, -4, and -9 on Monocytes and Dendritic Cells Depend on Patient Factors?. Cells 2024; 13(20): 1708 doi: 10.3390/cells13201708
|
2 |
Xiao-Jing Shi, Yu Song, Xue-Xue Liang, Ting Chen, Huang-Yu Hao, Xue Han, Ya-Nan Chen. Effects of Shenqi Xiangyi granules in advanced gastric cancer chemotherapy. World Journal of Gastrointestinal Oncology 2025; 17(1): 99272 doi: 10.4251/wjgo.v17.i1.99272
|
3 |
Franz Villarroel-Espíndola, Leyla Jaupi, Joaquín Reyes, Carlos Barrientos, Celia Podestá, Carolina Selman, Carolina Bizama, Alejandro Corvalan, Roxana Gonzalez-Stegmaier, Sergio Jara-Rosales, Pia Bascur. Spatial Study of TLR4, TLR5 and TLR9 in Gastric Premalignant Lesions Before and After Helicobacter pylori Eradication. International Journal of Molecular Sciences 2025; 26(9): 4059 doi: 10.3390/ijms26094059
|
4 |
Zitian Zheng, Huanhuan Luo, Qingyun Xue. U-shaped association of systemic immune-inflammation index levels with cancer-related and all-cause mortality in middle-aged and older individuals with frailty. Archives of Gerontology and Geriatrics 2024; 116: 105228 doi: 10.1016/j.archger.2023.105228
|
5 |
Mariana Cifuentes, Hugo E. Verdejo, Pablo F. Castro, Alejandro H. Corvalan, Catterina Ferreccio, Andrew F. G. Quest, Marcelo J. Kogan, Sergio Lavandero. Low-Grade Chronic Inflammation: a Shared Mechanism for Chronic Diseases. Physiology 2025; 40(1): 4 doi: 10.1152/physiol.00021.2024
|
6 |
Yuheng Zhang, Zhiyu Yan, Yuhao Jiao, Yunlu Feng, Shengyu Zhang, Aiming Yang. Innate Immunity in Helicobacter pylori Infection and Gastric Oncogenesis. Helicobacter 2025; 30(2) doi: 10.1111/hel.70015
|
7 |
Ye Liu, Lijia Zhang, Xue Lei, Xinyu Yin, Songjiang Liu. Development of an immunogenic cell death prognostic signature for predicting clinical outcome and immune infiltration characterization in stomach adenocarcinoma. Aging 2023; doi: 10.18632/aging.205132
|
8 |
Bei Ji, Zhiyuan Ma, Shuhui Liu, Shun Yao, Kenichi Mizuno, Shuji Terai, Biguang Tuo, Taolang Li, Xuemei Liu. Pyroptosis in gastric mucosal injury‑related diseases (Review). International Journal of Molecular Medicine 2025; 56(4): 1 doi: 10.3892/ijmm.2025.5606
|
9 |
Huanjun Li, Jingtang Chen, Zhiliang Chen, Jingsheng Liao. Predicting immune status and gene mutations in stomach adenocarcinoma patients based on inflammatory response-related prognostic features. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-02210-1
|